{"id":"W4410384052","doi":"10.1016/j.jhep.2025.05.003","title":"Durvalumab plus chemotherapy in advanced biliary tract cancer: 3-year overall survival update from the phase III TOPAZ-1 study","year":2025,"lang":"en","type":"article","venue":"Journal of Hepatology","topic":"Cholangiocarcinoma and Gallbladder Cancer Studies","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"AstraZeneca","keywords":"Durvalumab; Biliary tract cancer; Medicine; Topaz; Biliary tract; Chemotherapy; Cancer; Oncology; Internal medicine; Gemcitabine; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004574279,0.0006512899,0.002868365,0.0004934893,0.0002148423,0.001464995,0.000701659,0.0005048775,0.001471634],"category_scores_gemma":[0.003214485,0.0003049884,0.002702597,0.001128578,0.0002907196,0.001127624,0.0004910446,0.001980042,0.0002858666],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001195504,"about_ca_system_score_gemma":0.001017596,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00200023,"about_ca_topic_score_gemma":0.009200143,"domain_scores_codex":[0.9993719,0.0002574707,0.00008481841,0.00008510143,0.0001269025,0.00007380088],"domain_scores_gemma":[0.9977503,0.001008163,0.0006101839,0.0001497072,0.0002723638,0.0002091934],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.1162172,0.001544303,0.06118719,0.01009473,0.02331609,0.0001609601,0.0003124103,0.004341695,0.004281341,0.001056983,0.02924682,0.7482402],"study_design_scores_gemma":[0.1460517,0.0624753,0.4624757,0.00646952,0.09535483,0.001543637,0.0007123091,0.004394805,0.004835411,0.002957178,0.2124291,0.00030043],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.538373,0.4315566,0.002116531,0.005118436,0.001358678,0.0006247024,0.01186717,0.0001640153,0.008820966],"genre_scores_gemma":[0.7472803,0.2128268,0.00431425,0.007952905,0.001320116,0.0009170191,0.02234236,0.0001755048,0.002870741],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004574279,"threshold_uncertainty_score":0.02419144,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01994324393049175,"score_gpt":0.341977400279399,"score_spread":0.3220341563489073,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}